US HR279 | 2011-2012 | 112th Congress

Status

Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on May 25 2011 - 25% progression, died in committee
Action: 2011-06-03 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications. Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.

Sponsors


History

DateChamberAction
2011-06-03HouseReferred to the Subcommittee on Health.
2011-05-25HouseReferred to the House Committee on Energy and Commerce.

Subjects


US Congress State Sources


feedback